International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease

Williamson K, Lytvyak E, Kremer A, De Krijger M, Trivedi P, Estes D, Yu L, Pratt D, De Vries A, Yimam KK, Daretti L, Liu CH, Bowlus C, Vetter M, Marschall HU, Montano-Loza A, Chapman RWG, Marzioni M, Keshav S, Ponsioen C, Hirschfield G, Levy C (2018)


Publication Type: Conference contribution

Publication year: 2018

Journal

Publisher: ELSEVIER SCIENCE BV

City/Town: AMSTERDAM

Pages Range: S74-S75

Conference Proceedings Title: JOURNAL OF HEPATOLOGY

Event location: Paris FR

DOI: 10.1016/s0168-8278(18)30370-2

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Williamson, K., Lytvyak, E., Kremer, A., De Krijger, M., Trivedi, P., Estes, D.,... Levy, C. (2018). International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. In JOURNAL OF HEPATOLOGY (pp. S74-S75). Paris, FR: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:

Williamson, K., et al. "International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease." Proceedings of the International Liver Congress (ILC), Paris AMSTERDAM: ELSEVIER SCIENCE BV, 2018. S74-S75.

BibTeX: Download